Improving the Quality of life: The Implication of Intrathecal Baclofen in patients with Protracted Spasticity
Spasticity is defined as a velocity-dependent increase in muscle tone. Clinically, it becomes more visible with a rapid stretching movement. The pathogenesis of this clinical entity involves upper motor neuron dysfunction. Patients could present with minor muscle stiffness to uncontrollable, painful muscle contractions. This increased tonicity of multiple muscle groups throughout the body significantly impacts mobility and leads to altered posturing, pressure ulcers, and even leads to continence problems. All of these considerably impede these patients' daily lives.
2. Ghai A, Garg N, Hooda S, Gupta T. Spasticity–Pathogenesis, prevention and treatment strategies. Saudi J Anaesth. 2013; 7(4):453.
3. Kappa-Opioid PD. In: Proceedings of the AAPM 2016 Annual Meeting: Pain Medicine; 08 February 2016; Oxford University Press. 2013; 17(2): 381–441. Available at: https://academic.oup.com/painmedicine/article/17/2/381/2460775
4. Díaz RC, Lotero MA, Escobar DC. Intrathecal Baclofen for the treatment of spasticity. Case report with thematic review. Colombian J Anesth. 2013; 41(3):229-235.
5. Abou Al-Shaar H, Alkhani A. Intrathecal baclofen therapy for spasticity: A compliance-based study to indicate effectiveness. Surg. Neurol. Int. 2016; 7(Suppl 19):S539.
Copyright (c) 2020 The Author
This work is licensed under a Creative Commons Attribution 4.0 International License.
By submitting a manuscript in IJEHSR, the Author (Authors if a multi-authored paper) confirms all the clause of the Copyright Notice